An Open, Single Centre, Phase I Study in Male Adolescents With Asthma, Aged 12 to 17 Years, to Assess Pharmacokinetics of Orally Administered AZD1981 Tablets 100 mg Twice Daily for 61/2 Days.
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2013
At a glance
- Drugs AZD 1981 (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- Acronyms PEAK
- 21 Sep 2013 New source identified and integrated (European Clinical Trials Database; EudraCT2010-021520-10).
- 04 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 20 Jan 2011 Actual end date (Feb 2011) added as reported by ClinicalTrials.gov.